Related Experiment Video
Updated: Jan 28, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
[Methods and clinical values for minimal residual disease detection in patients with multiple myeloma]
1Department of Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University.
Abstract:
The complete response (CR) rates in patients with multiple myeloma (MM) have been rapidly increasing after the approval of novel agents such as proteasome inhibitors, immunomodulatory drugs, histone deacetylase inhibitors, and monoclonal antibodies. Recently, patients administered with a combination of novel agents with autologous stem-cell transplantation achieved a 70% CR rate. The assessment of minimal residual disease (MRD) is necessary for effective stratification of the CR cases and the generation of accurate prognoses. This review summarizes recent topics pertaining to MRD detection methods (multiparameter flow cytometry, allele-specific oligonucleotide real-time quantitative polymerase chain reaction, droplet digital PCR, and next-generation sequencing) and the prognostic value of MRD assessment in patients with MM.
Insights
Complete response rates in multiple myeloma are rising with new treatments. Minimal residual disease assessment is crucial for accurate prognoses and patient stratification.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Complete response (CR) rates in multiple myeloma (MM) are increasing due to novel agents and combination therapies.
- High CR rates, reaching 70% with novel agents and autologous stem-cell transplantation, necessitate refined prognostic tools.
- Minimal residual disease (MRD) assessment is vital for stratifying CR patients and improving prognoses.
Purpose of the Study:
- To review recent advancements in MRD detection methods for multiple myeloma.
- To summarize the prognostic significance of MRD assessment in multiple myeloma patients.
- To provide an overview of current MRD detection technologies and their clinical utility.
Main Methods:
- Multiparameter flow cytometry (MFC)
- Allele-specific oligonucleotide real-time quantitative PCR (ASO-qPCR)
- Droplet digital PCR (ddPCR)
- Next-generation sequencing (NGS)
Main Results:
- Multiple myeloma treatment landscape evolving with novel agents.
- High CR rates achieved with combination therapies and ASCT.
- MRD assessment is critical for prognosis and patient management.
Conclusions:
- MRD assessment is essential for accurate prognoses in multiple myeloma.
- Various sensitive techniques are available for MRD detection.
- Further research into MRD's role in MM management is warranted.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Types of Errors: Detection and Minimization
Absolute error in a measurement is the numerical difference from the true or central value. Relative error is the ratio between absolute error and the true or central value, expressed as a percentage.
Errors can be classified by source, magnitude, and sign. There are three types of errors: systematic, random, and gross.
Systematic or...
Biodiversity and Human Values
Professional Values
The values that are the foundation of the nursing profession are altruism, autonomy, human dignity, and social justice.
First, altruism refers to the concern for the welfare and well-being of others without personal...
Residual Plots
When the residual values are plotted against the variable x, it is called a residual...
Residual Stresses